Global Market Study on Microwave Ablation Devices (2019 - 2029) - Devices Based on Combination Therapies Mark Attractive Research Areas
- Rep Id : XPLREP3889
- Published On : May, 2019
- No. of Pages : 224
- Category : Medical Equipment
The increasing prevalence of cancers is one of the major factors contributing to the growth of the microwave ablation devices market. Hepatocellular Carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer related deaths worldwide. The liver is a common site for the development of primary metastases from other primary cancers, such as colorectal carcinoma. Lung cancer is the most frequent cancer and the leading cause of cancer-related deaths, followed by colorectal cancer.
While cancer has been one of the major causes of death worldwide, around 18 million new cancer cases were diagnosed globally, in 2018. By the end of 2030, this number is expected to double and cancers of breast and lung will be the most common types, worldwide. Currently, hepatocellular carcinoma and renal & adrenal diseases collectively account for more than 50% of the overall demand generated for microwave ablation devices.
High Adoption of Microwave Ablation Devices Prevails in Hospitals
Hospitals will remain prominent end users of microwave ablation devices, as a majority of patients continue to choose hospitals as their preference for seeking medical care. Cancer Research Institutes are also estimated to account for a significant share in the revenues of microwave ablation devices market over forthcoming years.
On the other side, the ambulatory surgical centres and specialised clinics segments collectively account for less than a fourth of the overall market value of microwave ablation devices.
Increasing Role of R&D in Raising Demand for Microwave Ablation Devices
The launch of new and improved products and increasing investments in research and development by the manufacturers of microwave ablation devices are expected to contribute to the growth of the global market over the forecast period.
For instance, on June 7, 2017, the AngioDynamics’ Solero Microwave Tissue Ablation System received FDA approval, following which it was launched for the ablation of soft tissues during open procedures. In March 2016, the company Ethicon (subsidiary of J&J) announced an agreement to acquire NeuWave Medical, Inc. for manufacturing minimally invasive tissue ablation systems.
Various policies have been imposed by governmental bodies, with an intent to regulate the alarming rate of cancer prevalence. Colorectal Cancer Control Program (CRCCP) that includes 30 states, universities, and tribal grantees across the U.S. Increase in cancer research finds has led to the establishment of several new dedicated cancer research institutes, which has been contributing majorly toward improved patient survival rates through the treatment enabled by microwave ablation systems, resulting in dramatic improvements in the quality of life for cancer patients.
Preference for Minimally Invasive Procedures Accelerating Demand Growth
Technological advancements and innovative imaging techniques, such as ultrasound and Magnetic Resonance Imaging (MRI), have improved the prospects of screening and survival for people living with cancer by providing health services that can focus on the early diagnosis and treatment of various diseases. Today, a considerably high number of people prefers minimally invasive surgical treatments.
Microwave ablation devices are used in minimally invasive surgeries to remove large-sized high-energy low-risk tumors. Moreover, tumors in kidney, lung, liver, and low-temperature parts of body are ideal to be treated with microwave ablation procedures.
These procedures assure a lower recurrence rate that tends to eliminate the need for patients to return to hospitals for the same treatment after a few months. This constitutes one of the most prominent advantages of microwave ablation devices, which will boost the demand for devices in global market.
The Future Points to Growing Potential of Devices Based on Combination Therapies
Microwave ablation overcomes the limitations of radiofrequency ablations, which also means that new methods that combine microwave ablation with chemotherapies, such as immunotherapy, point to the key research areas in the near future. Leading manufacturers of microwave ablation devices are thus aiming at developing new techniques with a combination of therapies for the treatment of tumours.
Microwave ablation is considered to be among the promising techniques that have the potential of treating a wide range of cancers such as biliary tract cancer, lung tumours, liver metastases, breast cancers, as well as arterial tissues.
A recent market study published by XploreMR, “Microwave ablation devices Market: Global Industry Analysis 2014-2018 & Forecast 2019-2029,” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the microwave ablation devices market, the growth prospects of the market are obtained with maximum precision.
The report commences with the executive summary of the microwave ablation devices market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the microwave ablation devices market.
Readers can find the detailed taxonomy and the definition of the microwave ablation devices market in this chapter, which will help them understand the basic information about the microwave ablation devices market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the microwave ablation devices market report.
The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations.
The next section includes the key inclusions of the report. It includes regulations, reimbursement scenario, epidemiology & opportunity analysis, and manufactures strategies for market expansion. Following chapter explains the global market value analysis and forecast for the microwave ablation devices market between the forecast periods of 2014-2029 is highlights in this section.
This chapter includes the detailed analysis of the historical microwave ablation devices market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).
The next section of the report highlights average price of microwave ablation systems and Microwave Probes/ Antennas in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section.
Next chapter depicts the global market volume analysis and forecast for the microwave ablation devices market between the forecast periods of 2019-2029 is highlights in this section.
The market background covered in the next chapter explains the key macro-economic factors that are expected to influence the growth of the microwave ablation devices market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the microwave ablation devices market.
This chapter also highlights the key market dynamics of the microwave ablation devices market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the microwave ablation devices market.
Based on product type, the microwave ablation devices market is segmented into microwave ablation systems and Microwave Probes/ Antennas. In this chapter, readers can find information about the key trends and developments in the microwave ablation devices market and market attractiveness analysis based on the product type.
Based on application, the microwave ablation devices market is segmented into Hepatocellular Carcinoma, Colon Cancer, Renal and Adrenal Disease, Bone Malignancies and Lung Tumors. In this chapter, readers can find information about the key trends and developments in the microwave ablation devices market and market attractiveness analysis based on the applications.
The end-user analysis section provides details about the microwave ablation devices market on the basis of end user, and has been classified into hospitals, Cancer Research Institutes, Specialized clinics and ambulatory surgical centres. In this chapter, readers can understand the market attractive analysis based on end user.
The next section covers regional analysis and elaborated on how the microwave ablation devices market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA).
The report further includes in-depth market structure analysis, followed by analysis of the competition in global market landscape. Here, readers can find a comprehensive list of all the leading stakeholders in the Microwave ablation devices market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments.
Some of the market players featured in the report are
- AngioDynamics, Inc.
- Johnson & Johnson
- Medtronic Plc.
- Perseon Corporation
- Terumo Europe NV
- Vison Medical USA.
- ECO Inc.
- MedWaves, Inc.
- Urologix, LLC.